{"nct_id":"NCT05120349","title":"A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2022-02-21","start_date_type":"ACTUAL","primary_completion_date":"2027-08-02","primary_completion_date_type":"ESTIMATED","completion_date":"2032-11-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}